These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 17925561)

  • 21. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
    Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
    Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical behaviour of authors in biomedical journalism.
    Bevan JC
    Ann R Coll Physicians Surg Can; 2002 Mar; 35(2):81-5. PubMed ID: 12755122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Funding source and conflict of interest disclosures by authors and editors in gastroenterology specialty journals revisited.
    Qureshi J; Sud A; Vakil N
    Aliment Pharmacol Ther; 2012 Mar; 35(6):690-5. PubMed ID: 22257079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintaining the trust of physicians and the public in the medical literature: report of a task force on scientific publishing of clinical trials.
    Shane E; Civitelli R; Delmas PD; Drezner M; Eisman JA; Lindsay R; Lorenzo J; Miller P; Ralston S; Reid I; Siris E
    J Bone Miner Res; 2007 Nov; 22(11):1661-7. PubMed ID: 17907954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature.
    Khan SN; Mermer MJ; Myers E; Sandhu HS
    Am J Orthop (Belle Mead NJ); 2008 Dec; 37(12):E205-12; discussion E212. PubMed ID: 19212579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
    J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conflict of interest in the debate over calcium-channel antagonists.
    Stelfox HT; Chua G; O'Rourke K; Detsky AS
    N Engl J Med; 1998 Jan; 338(2):101-6. PubMed ID: 9420342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of journal instructions regarding institutional review board approval and conflict-of-interest disclosure between 1995 and 2005.
    Rowan-Legg A; Weijer C; Gao J; Fernandez C
    J Med Ethics; 2009 Jan; 35(1):74-8. PubMed ID: 19103950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disclosure of industry relationships by anesthesiologists: is the conflict of interest resolved?
    Kofke WA
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):177-83. PubMed ID: 20084000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A descriptive analysis of the Journal of Manipulative and Physiological Therapeutics, 1989-1996.
    Keating JC; Caldwell S; Nguyen H; Saljooghi S; Smith B
    J Manipulative Physiol Ther; 1998 Oct; 21(8):539-52. PubMed ID: 9798183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haunted manuscripts: ghost authorship in the medical literature.
    Ngai S; Gold JL; Gill SS; Rochon PA
    Account Res; 2005; 12(2):103-14. PubMed ID: 16220624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrepancy between results and abstract conclusions in industry- vs nonindustry-funded studies comparing topical prostaglandins.
    Alasbali T; Smith M; Geffen N; Trope GE; Flanagan JG; Jin Y; Buys YM
    Am J Ophthalmol; 2009 Jan; 147(1):33-38.e2. PubMed ID: 18760766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The magnitude and nature of unfunded published cardiovascular research.
    Mai TV; Agan DL; Clopton P; Collins G; DeMaria AN
    J Am Coll Cardiol; 2013 Jan; 61(3):275-81. PubMed ID: 23219303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Academic medical centers' standards for clinical-trial agreements with industry.
    Mello MM; Clarridge BR; Studdert DM
    N Engl J Med; 2005 May; 352(21):2202-10. PubMed ID: 15917385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
    Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Eur Heart J; 2012 Mar; 33(5):587-94. PubMed ID: 22383145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Financial conflicts of interest among ASCO annual meeting abstract authors, speakers, and planners.
    Johnston KL; Go RS
    J Natl Cancer Inst; 2007 Sep; 99(18):1415-6. PubMed ID: 17848676
    [No Abstract]   [Full Text] [Related]  

  • 40. Nursing Journal Policies on Disclosure and Management of Conflicts of Interest.
    Barnsteiner J; Shawn Kennedy M; Flanagin A; Sietmann C
    J Nurs Scholarsh; 2020 Nov; 52(6):680-687. PubMed ID: 33078574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.